0001104659-22-071892.txt : 20220616
0001104659-22-071892.hdr.sgml : 20220616
20220616161040
ACCESSION NUMBER: 0001104659-22-071892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARKER SAM L
CENTRAL INDEX KEY: 0001226877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50626
FILM NUMBER: 221020659
MAIL ADDRESS:
STREET 1: 51 AUNT MOLLY ROAD
CITY: HOPEWELL
STATE: NJ
ZIP: 08525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001130166
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911766850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-7330
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER COMPANY:
FORMER CONFORMED NAME: XCYTE THERAPIES INC
DATE OF NAME CHANGE: 20001218
4
1
tm2218645-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-14
0
0001130166
Cyclacel Pharmaceuticals, Inc.
CYCC
0001226877
BARKER SAM L
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS
NJ
07922
1
0
0
0
Common Stock
2022-06-14
4
A
0
15822
0
A
19196
D
Stock Option (right to buy)
1.11
2022-06-14
4
A
0
31645
0
A
2023-06-14
2032-06-14
Common Stock
31645
31645
D
The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023.
These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
/s/ Sam L. Barker
2022-06-16